Analysis of immune-related adverse events correlated with good prognosis in melanoma treatment and fluctuating blood factors

J Dermatol. 2023 Apr;50(4):565-567. doi: 10.1111/1346-8138.16692. Epub 2022 Dec 20.

Authors

Kenta Nakamura¹, Atsuko Ashida¹, Yukiko Kiniwa¹, Ryuhei Okuyama¹

Affiliation

¹ Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.

PMID: 36539945
DOI: 10.1111/1346-8138.16692

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Humans
Ipilimumab / adverse effects
Melanoma* / drug therapy
Prognosis
Skin Neoplasms* / chemically induced
Skin Neoplasms* / diagnosis

Substances

Ipilimumab